Diagnosis and course of osteoporosis in patients with type 2 diabetes mellitus (literature review and own data)

Authors

  • Titova J. O. SI «V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine», Kharkiv, Ukraine
  • Kravchun N. A. SI «V. Danilevsky Institute for endocrine pathology problems National Academy of Medical sciences of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2017.3.13

Keywords:

osteoporosis, type 2 diabetes mellitus, nonalcoholic fatty liver disease, bone mineral density

Abstract

In the presented review, the relevance of studying the course and development of osteoporosis in patients with type 2 diabetes combined with non-alcoholic fatty liver disease is substantiated. It is shown that there is a clear relationship between the level of glucose, bone metabolism and the functional state of the liver. A number of the presented studies testify to the important role of vitamin D in the development of osteoporotic changes in patients with type 2 diabetes and dictates the need for its determination in the above-mentioned contingent of patients. The results of the authors’ own studies demonstrated a clinically significant association of hepatic transaminases with the parameters of phosphorus-calcium metabolism in women with type 2 diabetes mellitus in combination with non-alcoholic fatty liver disease. The results obtained require further detailed study.

References

World Health Organization. Global report on diabetes 2016: 88 р.

Wojcicka A, Bassett JHD, Williams GR. Biochim Biophys Acta 2013; 1830(7):3979-3986.

Korzh NA, Jakovenchuk NN, Deduh NV. Ortopedija, Travmatologija i Protezirovanie 2013; 4:102-110.

Kovalenko VN, Bortkevich OP. Ukr Revmatol Zhurn 2010; 3:15-20.

Povoroznjuk VV, Grigor’eva NV. Menopauza i kostno-myshechnaja sistema, Kiev, 2004: 511 p.

Povoroznjuk VV, Dmytrenko OP, Verba OI, Makarenko VM. Rentgenivs’ka absorbciometrija v diagnostyci systemnogo osteoporozu: metod. rekomendacii’, Kyi’v, 2003: 27 p.

Larin OS, Kyryljuk ML, Tretjak OE, et al. Klin Endokrynol Endokryn Hirurgija 2014; 1(4б):3-14.

Bonnet N. Osteoporoz i Osteopenii 2016; 1:12.

Hita-Contreras F, Martinez-Amat A, Cruz — D. Diaz, et al. Maturitas 2015; 80(2):126-132. https://doi.org/10.1016/j.maturitas.2014.11.009

Zjablicev SV, Larin OS, Zjablicev DS. Klin Endokrynol Endokryn Hirurgija 2015; 4(52):7-11.

Fulzele K, Riddle RC, DiGirolamo DJ, et al. Cell 2010; 142(2):309-319.

Ferron M, McKee MD, Levine RL, et al. Bone 2012; 50(2):568-575.

Wei J, Ferron M, Clarke CJ, et al. J Clin Invest 2014; 124(4):1-13.

Bodnar LM, Catov JM, Roberts JM, et al. J Nutr 2007; 137(11):2437-2442.

Ford ES, Ajani UA, McGuire LC, et al. Diabetes Care 2005; 28(5):1228-1230.

Andreopoulou P, Bookman RS. Ann Rev Med 2015; 14:329-342.

Klein-Nulend J, van Qers RF, Bakker AD, et al. J Biomech 2014; 21:26-30.

Rizzoli R, Bischoff-Ferrari H, Dawson-Hughes B, et al. Womens Health 2014; 10(6):599-608.

Vertkin AL, Morgunova LJu, Naumova AV. Osteoporoz i Osteopatologija 2007; 1:25-28.

Kazimirko VK, Kovalenko VN, Mal’cev VI. Osteoporoz: patogenez, klinika, profilaktika i lechenie, Kiev, 2007: 160 p.

Barsova AP, Mascarenhas MR. Mizhnar Endokrynol Zhurn 2015; 8(72):61-66.

Povoroznjuk VV, Balac’ka NІ, Klimovic’kij FV, Sinen’kij OV. Travma 2012; 13(4):12-16.

Povoroznjuk VV, Martinjuk LP. Mizhnar Endokrynol Zhurn 2016; 3(75):13-18.

Problemy deficytu ta nedostatnosti vitaminu D v ukrai’ns’kij ta portugal’s’kij populjacijah: osnovni pytannja (v ramkah pershoi’ ukrai’ns’ko-portugal’s’koi’ konferencii’ z pytan’ osteoporozu, m. Lisabon, Portugalija). Mizhnar Endokrynol Zhurn 2016; 5(77):90-98.

Povoroznjuk VV, Synen’kyj OV, Balac’ka NI, et al. Mizhnar Endokrynol Zhurn 2016; 5(77):20-24.

Maeema НЕ, Меета S. Can Med Assoc J 1967; 96(3):132-139.

Kiriljuk ML, Atanova JaO, Dogotar VB. Mizhnar Endokrynol Zhurn 2016; 8(80):35-39.

Johnston CC, Hui SL, Longcope C. Metabolism 1985; 34(6):544-550.

Orlenko VL. Endokrynologija 2016; 21(4):359-365.

Giacca A, Fassina A, Caviezel F, et al. Bone 1988; 9(1):29-36.

Wakasugi M, Wakao R, Tawata M, et al. Bone 1993; 14(1):29-33.

Sosa M, Dominguez M, Navarro MC, et al. J Diabetes Complications 1996; 10(4):201-205.

Hampson G, Evans C, Petitt R, et al. J Diabetol 1998; 41(11):1314-1320.

Gregorio F, Cristallini S, Santeusanio F, et al. Diabetes Res Clin Pract 1994; 23(1):43-54.

Majima T, Komatsu Y, Yamada T, et al. Osteoporos Int 2005; 16(8):907-913.

Zhou Y, Li Y, Zhang D, et al. Diabetes Res Clin Pract 2010; 90(3):261-269.

Gerdhem P, Akesson K. J Bone Joint Surg Br 2007; 89(12):1627-1631.

Vestergaard P. Osteoporos Int 2007; 18(4):427-444.

Garnero P, Vergnaud P, Hoyle N. Clin Chem 2008; 54(1):188-196.

Yamamoto M, Yamaguchi T, Yamauchi M, et al. Calcif Tissue Int 2007; 80(6):353-358.

Yamamoto M, Yamaguchi T, Yamauchi M, et al. J Bone Miner Res 2009; 24(4):702-709.

Saneeva GA, Aleksandrovich GA, Bunyaeva EM, et al. Advances Curr Nat Sci 2015; 3:82-86.

Kiriljuk ML, Atanova JaO, Tretjak OE. Mizhnar Endokrynol Zhurn 2016; 1(73):87-91.

Ocheretina RJu. Uspehi Sovremennogo Estestvoznanija 2015; 2:89-93.

Tkach SM, Cheverda TL. Klin Endokrynol Endokryn Hirurgija 2016; 1:60-70.

Yilmaz Y. Aliment Pharmacol Ther 2012; 36(4):345-352.

Karimov MM, Saatov ZZ, Sobirova GN, et al. Profilaktika, diagnostika i lechenie zabolevanij organov pishhevarenija v HHІ veke: materialy 14-go s#ezda nauchnogo obshhestva gastrojenterologov Rossii, Sankt-Peterburg, 2014: 41.

Downloads

Published

2021-06-24

How to Cite

Titova, J. O., & Kravchun, N. A. (2021). Diagnosis and course of osteoporosis in patients with type 2 diabetes mellitus (literature review and own data) . Problems of Endocrine Pathology, 61(3), 94-101. https://doi.org/10.21856/j-PEP.2017.3.13

Most read articles by the same author(s)

1 2 3 > >>